🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Wisconsin › Madison

Myelodysplastic Syndromes clinical trials in Madison, WI

5 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • William S Middleton VA Medical Center, Madison
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06577441

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

RecruitingPhase 1
  • University of Wisconsin Carbone Cancer Center, Madison
7 Months – 21 Years · All sexes · Updated Oct 16, 2025 · NCT02508038

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RecruitingPhase 1
  • University of Wisconsin Clinical Science Center, Madison
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196

About Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

More about Myelodysplastic Syndromes on MedlinePlus

Myelodysplastic Syndromes trials in other cities

Other studies in Madison

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.